Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
about
Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system.Common variants of the vitamin D binding protein gene and adverse health outcomesImmunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAFInvestigation of Vitamin D-Binding Protein Polymorphism Impact on Coronary Artery Disease and Relationship with Longevity: Own Data and a ReviewRegulation of inflammation-primed activation of macrophages by two serum factors, vitamin D3-binding protein and albumin.Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosisSingle nucleotide polymorphism and haplotype effects associated with somatic cell score in German Holstein cattleRelationship of vitamin D binding protein polymorphisms and lung function in Korean chronic obstructive pulmonary diseaseVitamin D deficiency in chronic liver disease.Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice.Circulating vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D and risk of colorectal cancerIs vitamin D binding protein a novel predictor of labour?The genetics of chronic obstructive pulmonary disease.Vitamin D-binding protein gene polymorphisms and chronic obstructive pulmonary disease susceptibility: A meta-analysisLack of association of group specific component haplotypes with lung function in smokersFine mapping of a QTL on bovine chromosome 6 using imputed full sequence data suggests a key role for the group-specific component (GC) gene in clinical mastitis and milk production.Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis.The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy.Cross-talk among structural domains of human DBP upon binding 25-hydroxyvitamin D.Relationship between vitamin D-binding protein polymorphisms and blood vitamin D level in Korean patients with COPD.Fatty acid-binding site environments of serum vitamin D-binding protein and albumin are different.Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.Phenotypes of chronic obstructive pulmonary disease.Glycosylation status of vitamin D binding protein in cancer patients.Genes involved in innate immunity associated with asbestos-related fibrotic changesPlasma Actin-free Gc-globulin in Patients with Chronic or Acute-on-chronic Liver Failure Caused by Hepatitis B Virus.Placental Vitamin D-Binding Protein Expression in Human Idiopathic Fetal Growth Restriction.An update on vitamin D and human immunity.Linkage between vitamin D-binding protein and alpha-fetoprotein in the mouse.Vitamin D-Binding Protein in Health and Chronic Kidney Disease.A mass spectrometric insight into the origins of benign gynecological disorders.Tumour-associated macrophages as treatment targets in oncology.Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4.Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.Phenotype of Gc-globulin influences the macrophage activating factor (MAF) levels in serum.Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk.Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS.Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D(3) does not influence this activity.Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.
P2860
Q24534384-1D2F98D6-35A3-48E4-ABDE-3257ABC3BDE6Q24596671-0A9147EC-0446-46CD-9105-F988F96C9349Q24645388-11992C65-AEF9-4157-B03B-BD92CC9DEF84Q31090216-EBA99555-B7A9-4C39-8540-A879A4B24524Q33618000-A0E71625-875D-4D3B-B5F7-5614F10A6D33Q33735371-E47AC1D0-BA48-41CD-9564-FFE5A566593EQ33835639-2302594F-CDC0-4E9C-AD91-35667245E552Q33941637-33D2FA4F-AFB1-40BE-988F-295154D6C6A3Q34728285-0E6E28BD-0F63-4E0B-BE8E-10833FA030FDQ34770185-57BE178A-F84B-48A3-812D-213E40BA135DQ34997116-AE9DEB34-076A-4913-AAE9-7ACE7D9BE643Q35016991-A5747933-340C-4C68-9F99-6E823F619BEEQ35113365-F4D53444-13C4-4E28-AA06-C0D59FACE2FBQ35180085-3924E522-0A54-4255-A17C-751897B98C5FQ35536150-608DCCAD-2FE1-4728-ABFF-CFBBFC6DC1E0Q36168180-F0EFF5F4-DC8F-4316-9F18-BD9A4005ACA4Q36238059-69CE3F25-4CAE-4E7D-B0E0-0019E387D481Q36292222-97801A7B-29E9-4038-8394-6E77FF1C59E7Q36326033-D341EFBC-8188-4F42-9802-9BF56B75E510Q36787740-4C1EDB0A-6F8C-4DBD-AFA0-96CA981EEF3BQ36798805-D799E79A-09A0-465F-8780-FF7C8B687B8CQ36888680-8FF44BC7-6D8C-4B7C-AC41-DC16D179A1DEQ37008634-DE6BBD69-1C07-41D1-A0B1-4EC4A55A69F4Q37452925-315BEBAC-634E-4D31-8E4C-C401A289534DQ37465454-598C6D6A-8B7B-4862-A0A8-994BBB352012Q37477542-8A51B803-02D8-4DA0-B624-702CF809F88BQ37672808-8B702FC0-FE09-48AE-8FF3-E71B0202C623Q37945341-6F905887-9BC9-41F4-AC6A-23A4A2DAE998Q38362048-E3309402-048B-45FE-A030-AE8D9A723F4FQ38579149-48A32ECC-CA39-4CC6-AD1A-DC7A568DA103Q38657980-EA414255-8501-4C19-8DB3-3C2C0A3F3789Q39100693-3D64F9BD-332F-4182-A9CC-492E5562B664Q39305177-D53E77C8-89A1-4AA4-AA7C-FC67A006CCCAQ39416382-DA68B2C9-ACB9-4F99-95F1-EDAEC105962BQ39712950-F6796F8F-09CC-4CEB-969A-0F82EC1CBFF6Q39715279-3BE30E22-46F9-40D8-B409-3338E4693657Q40947511-60CF252D-85AE-4B1C-87E5-7371101A8ABBQ42100819-7A3F1905-3A4B-4F77-B05E-2C3239FE0B9BQ43545797-32D49E82-D0E2-40C3-A70E-59B25F9719D2Q43824829-BE8674F5-70F7-41E7-A320-691D8AD8DCDD
P2860
Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vitamin D3 binding protein (gr ...... ylcholine-treated lymphocytes.
@en
Vitamin D3 binding protein
@nl
type
label
Vitamin D3 binding protein (gr ...... ylcholine-treated lymphocytes.
@en
Vitamin D3 binding protein
@nl
prefLabel
Vitamin D3 binding protein (gr ...... ylcholine-treated lymphocytes.
@en
Vitamin D3 binding protein
@nl
P2860
P921
P356
P1476
Vitamin D3 binding protein (gr ...... ylcholine-treated lymphocytes.
@en
P2093
P2860
P304
P356
10.1073/PNAS.88.19.8539
P407
P577
1991-10-01T00:00:00Z